-
TIGER-LC High-Throughput Sequencing
Study
phs001199
-
CALGB 40601: Randomized Phase III Trial of Paclitaxel Combined With Trastuzumab, Lapatinib, or Both As Neoadjuvant Treatment of HER2-Positive Primary Breast Cancer
Study
phs001570
-
A Clone's Genomic Stability as a Biomarker of Its DNA-Damage Resilience
Study
phs003762
-
Multi-Modal Single-Cell, Spatial, and Genomic Analyses of Human Non-Small Cell Lung Cancer Brain Metastases
Study
phs003865
-
Metabolic Biomarkers in Thoracic Cancers
Study
phs003880
-
National Cancer Institute Multi-Ancestry Genome-Wide Association Study of Kidney Cancer (NCI-3)
Study
phs003505
-
A Personalized Neoantigen Vaccine Generates Anti-Tumor Immunity in High-Risk Renal Cell Carcinoma
Study
phs003710
-
NRG-GY017: Atezolizumab before and/or with Chemoradiotherapy in Immune System Activation in Patients with Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer
Study
phs003833
-
Results of RNA sequencing from all patients/samples
Dataset
EGAD50000000017
-
Gene Expression Signature in Normal Mammary Gland from 83 Breast Cancer Patients Indicates Pre-tumorous Changes and Adverse Outcomes
Study
EGAS50000000011